3 hours Oppenheimer Increases Immunovant (NASDAQ:IMVT) Price Target to $53.00 MarketBeat
Oppenheimer upped their price objective on Immunovant from $47.00 to $53.00 and gave the company an “outperform” rating in a research report on Wednesday.
Oppenheimer upped their price objective on Immunovant from $47.00 to $53.00 and gave the company an “outperform” rating in a research report on Wednesday.